These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3389753)

  • 61. The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.
    Hosokawa M; Mizukoshi T; Morikawa K; Xu ZY; Kobayashi H
    Cancer Immunol Immunother; 1986; 22(3):181-5. PubMed ID: 3731203
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Combination therapy of cancer of the colon].
    Miasoedov DV; Evtushenko OI; Kinevskiĭ OF
    Klin Khir (1962); 1989; (5):4-6. PubMed ID: 2754974
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukins and colon cancer.
    Caro-Patón Gómez A
    Rev Esp Enferm Dig; 2005 Sep; 97(9):613-8. PubMed ID: 16266233
    [No Abstract]   [Full Text] [Related]  

  • 64. Increased survival of CD1 mice bearing dimethylhydrazine induced primary colon and anal cancers by difluoromethylornithine with concomitant increase in angiosarcoma incidence.
    Benrezzak O; Nigam VN; Madarnas P
    Anticancer Res; 1987; 7(2):251-7. PubMed ID: 3109315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of single and combined maltose tetrapalmitate immunotherapy, cyclophosphamide chemotherapy and radiotherapy on ethyl carbamate accelerated primary lung cancer in A/J mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    In Vivo; 1988; 2(2):159-65. PubMed ID: 2979834
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
    Nigam VN; Brière N; Bonaventure J; Pageau R; Bissonnette E; Brailovsky C; Madarnas P
    Anticancer Res; 1986; 6(2):245-50. PubMed ID: 3085575
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
    Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
    Hollinshead A
    Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.